Celmune Therapeutics is Drug Discovery in United States that focus on hematologic malignancies business. Founded in 2015. They cover business area such as developer, medicine, cell development, metabolic disease, small molecule immune-oncology agent, solid tumor, hematologic malignancy, patient, advanced treatment, their disease.
2015
( 9 years old in 2024 )
Hematologic Malignancies
-
DE
United States
Private
developermedicinecell developmentmetabolic diseasesmall molecule immune-oncology agentsolid tumorhematologic malignancypatientadvanced treatmenttheir disease
* We use standard office opening hours in near Celmune Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Celmune Therapeutics is Drug Discovery business from United States that founded in 2015 (9 years old in 2024), Celmune Therapeutics business is focusing on Hematologic Malignancies.
Celmune Therapeutics headquarter office and corporate office address is located in DE United States.
Celmune Therapeutics was founded in United States.
In 2024, Celmune Therapeutics is currently focus on hematologic malignancies sector.
Above is snippet of Google Trends for "hematologic malignancies" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Celmune Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
